![George Migausky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Migausky
Directeur/Membre du Conseil chez
REGENXBIO INC.
Fortune : 6 M $ au 30/06/2026
Profil
George V.
Migausky currently serves as Independent Director at REGENXBIO, Inc. since 2021, Director at Immunovant Sciences Ltd. since 2020, and Trustee at Massachusetts Eye & Ear Infirmary, Inc. since 2015.
Former roles include Independent Director at Abeona Therapeutics, Inc. in 2020, Independent Director at Immunovant, Inc. from 2019 to 2025, Independent Director at Dimension Therapeutics, Inc. from 2015 to 2017, Director at Rocket Pharmaceuticals, Inc., Director at Health Sciences Acquisitions Corp., Director at Immunovant, Inc., Independent Director at Hyperion Catalysis International, Inc. from 2008 to 2022, Chief Financial Officer & Executive Vice President at Dyax Corp.
from 2010 to 2016, Chief Financial Officer & Vice President at BioVeris Corp.
from 1986 to 2007, Chief Financial Officer at Ocular Therapeutix, Inc. in 2017, Chief Financial Officer & Vice President at IGEN International, Inc. from 1986 to 2004, Manager at Deloitte & Touche, and Chief Financial Officer at Wellstat Management Co. LLC.
from 2007 to 2008.
Education includes an MBA from Babson College and an undergraduate degree from Boston College conferred in 1976.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNOVANT INC 0,07 % | 01/04/2025 | 137 251 ( 0,07 % ) | 5 M $ | 30/06/2026 |
REGENXBIO, INC. 0,06 % | 29/05/2026 | 28 861 ( 0,06 % ) | 345 755 $ | 30/06/2026 |
Postes actifs de George Migausky
| Sociétés | Poste | Début |
|---|---|---|
| REGENXBIO INC. | Directeur/Membre du Conseil | 03/09/2021 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Directeur/Membre du Conseil | 01/03/2020 |
Massachusetts Eye & Ear Infirmary, Inc.
 Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Provides vision and hearing treatments | Directeur/Membre du Conseil | 01/01/2015 |
Anciens postes connus de George Migausky
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOVANT, INC. | Directeur/Membre du Conseil | 18/04/2025 |
Hyperion Catalysis International, Inc.
 Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Manufactures plastic tubes | Directeur/Membre du Conseil | 01/08/2022 |
| ABEONA THERAPEUTICS INC. | Directeur/Membre du Conseil | 27/09/2020 |
| DIMENSION THERAPEUTICS INC | Directeur/Membre du Conseil | 07/11/2017 |
| OCULAR THERAPEUTIX, INC. | Directeur Financier/CFO | 25/09/2017 |
Formation de George Migausky
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Health Technology |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deloitte & Touche
 Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Provides audit, enterprise risk management and financial advisory services | Commercial Services |
Massachusetts Eye & Ear Infirmary, Inc.
Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Provides vision and hearing treatments | Health Services |
Wellstat Management Co. LLC
 Wellstat Management Co. LLC Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Hyperion Catalysis International, Inc.
Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Manufactures plastic tubes | Producer Manufacturing |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Health Sciences Acquisitions Corp.
 Health Sciences Acquisitions Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Immunovant, Inc. /Old/
 Immunovant, Inc. /Old/ BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
